|Chinmoy Sankar Dey Professor, Kusuma School of Biological Sciences Indian Institute of Technology Delhi, Hauz Khas, New Delhi 110016, India. Ph: 91-11-26597523 Email: firstname.lastname@example.org||
Current Research Interests
1. Insulin resistant (Type 2) diabetes: Molecular mechanism(s), Signal transduction, target(s) identification.
2. Drug resistance in Leishmania: Molecular mechanism(s) / target(s) identification
TEACHING EXPERIENCE : 12 years (1998-till date)
AWARDS AND HONORS:
· Fellow of the National Academy of Sciences (FNASc), India, 2007.
· J.C.Bose Fellowship from the Department of Science and Technology, Govt. of India; 2008
· Press Release in Nature: News India
· Hottest 25 Papers: Science Direct: Molecular and Biochemical Parasitology, 141, 1, 2005
· Cover Page: Molecular and Biochemical Parasitology, 141, 1, 2005
· BMC Cell Biology, 2008, 9: 48: 1408 pdf reprints downloaded within 3 months of publication
CONSULTANCY (Pharmaceutical company):
· Orchid Chemicals and Pharmaceutical Ltd., Chennai
PUBLICATIONS (Representatives of research areas of last 5 years):
1 Sharma S, Singh G, Chavan HD, and Dey CS. Proteomic analysis of wild type and arsenite resistant Leishmania donovani. Exp Parasitol. 2009, 123.
2 Gupta A and Dey CS: PTEN and SHIP2 regulates PI3K/ Akt pathway through Focal adhesion kinase. Mol. Cell. Endocrionol. 2009, 123:55.
3 Singh GM, Thakur M, Chakraborti PK and Dey CS: Evidence for the presence of R250G mutation at the ATPase domain of Topoisomerase II in an arsenite-resistant L. donovani that exhibits differential drug inhibition profile. Int. J. Antimicrob. Agents 2009, 33: 80.
4 Bisht B and Dey CS: Focal Adhesion Kinase contributes to insulin-induced actin reorganization into a mesh harboring Glucose transporter-4 in insulin resistant skeletal muscle cells. BMC Cell Biology 2008, 9: 48.
5 Bisht B, Srinivasan K and Dey CS. In vivo inhibition of Focal Adhesion Kinase causes insulin resistance. J. Physiology, 2008, 586/16: 3825.
6 Singh GM , Chavan HD and Dey CS: Proteomic analysis of miltefosine resistant Leishmania reveals the possible involvement of eukaryotic initiation factor 4A, eIF4A. Int. J. Antimicrob. Agents 2008, 31: 581.
7 Badiwala, HS, Singh G, Singh, R, Dey CS, Sharma, SS, Bhutani, KK and Singh IP: Antileishmanial amides and lignans from Piper cubeba and Piper retrofractum. J. Nat. Med. 2007, 61: 418.
8 Singh, G, and Dey CS. Induction of apoptosis-like cell death by pentamidine and doxorubicin through differential inhibition of topoisomerase II in arsenite-resistant L. donovani. Acta Tropica, 2007, 103: 172.
9 Chavan, HD, Singh, G and Dey CS. Confocal microscopic investigation of tubulin distribution and effect of paclitaxel on post-translationally modified tubulins in sodium arsenite resistant Leishmania donovani. Exptl. Parasitol. 2007, 116 ; 320.
10 Bisht, B, Goel, HL and Dey, CS. Focal Adhesion Kinase regulates insulin resistance in skeletal muscle. Diabetologia, 2007, 50:1058.
11 Verma, NK, Singh, G and Dey, CS. Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction. Exptl. Parasitol., 2006, 116: 1
12 Singh, J, Verma, NK, Kansagra Sejal M, Kate, B and Dey, CS. Altered PPARg expression inhibits myogenic differentiation in C2C12 skeletal muscle cells. Mol. Cell. Biochem. 2007, 294: 163.
13 Verma, NK and Dey, CS. Anti-leishmanial drug miltefosine causes insulin resistance in skeletal muscle cells in vitro. Diabetologia, 2006, 49:1656.